68Ga-Df12-exendin-4

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Name68Ga-Df12-exendin-4
Drug Alias Name68Ga-labeled exendin-4 derivative (Arkray Inc)
ClassificationSmall molecules > PeptidomimeticRadiation-emitting products
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsInsulinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArkray Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArkray Inc
Active IndicationsN/A
Inactive IndicationsInsulinoma

Other Information

ATC CodeN/A
Related LinksN/A